• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活方式改变对慢性乙型肝炎患者肝细胞癌发病率和死亡率的影响。

Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B.

机构信息

Department of Internal Medicine, Kyung Hee University Hospital, Seoul 02447, South Korea.

Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul 06355, South Korea.

出版信息

World J Gastroenterol. 2023 Jun 28;29(24):3843-3854. doi: 10.3748/wjg.v29.i24.3843.

DOI:10.3748/wjg.v29.i24.3843
PMID:37426323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10324530/
Abstract

BACKGROUND

Research exploring the influence of healthier lifestyle modification (LSM) on the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is limited.

AIM

To emulate a target trial to determine the effect of LSM on HCC incidence and mortality among patients with CHB by large-scale population-based observational data.

METHODS

Among the patients with CHB enrolled in the Korean National Health Insurance Service between January 1, 2009, and December 31, 2017, those aged ≥ 20 years who drank alcohol, smoked cigarettes, and were sedentary were analyzed. Exposure included at least one LSM, including alcohol abstinence, smoking cessation, and regular exercise. The primary outcome was HCC development, and the secondary outcome was liver-related mortality. We used 2:1 propensity score matching to account for covariates.

RESULTS

With 48766 patients in the LSM group and 103560 in the control group, the adjusted hazard ratio (HR) for incident HCC and liver-related mortality was 0.92 [95% confidence interval (CI): 0.87-0.96] and 0.92 (95%CI: 0.86-0.99) in the LSM group, respectively, compared with the control group. Among the LSM group, the adjusted HR (95%CI) for incident HCC was 0.84 (0.76-0.94), 0.87 (0.81-0.94), and 1.08 (1.00-1.16) for alcohol abstinence, smoking cessation, and regular exercise, respectively. The adjusted HR (95%CI) for liver-related mortality was 0.92 (0.80-1.06), 0.81 (0.72-0.91), and 1.15 (1.04-1.27) for alcohol abstinence, smoking cessation, and regular exercise, respectively.

CONCLUSION

LSM lowered the risk of HCC and mortality in patients with CHB. Thus, active LSM, particularly alcohol abstinence and smoking cessation, should be encouraged in patients with CHB.

摘要

背景

针对更健康的生活方式改变(LSM)对慢性乙型肝炎(CHB)患者肝细胞癌(HCC)风险影响的研究有限。

目的

利用大规模基于人群的观察性数据,通过模拟目标试验来确定 LSM 对 CHB 患者 HCC 发病率和死亡率的影响。

方法

在 2009 年 1 月 1 日至 2017 年 12 月 31 日期间参加韩国国家健康保险服务的 CHB 患者中,分析年龄≥20 岁且饮酒、吸烟和久坐的患者。暴露包括至少一种 LSM,包括戒酒、戒烟和定期运动。主要结局是 HCC 的发生,次要结局是与肝脏相关的死亡率。我们使用 2:1 的倾向评分匹配来考虑协变量。

结果

在 LSM 组中,有 48766 名患者,在对照组中有 103560 名患者,与对照组相比,LSM 组 HCC 发生率和与肝脏相关的死亡率的调整后的危险比(HR)分别为 0.92(95%置信区间[CI]:0.87-0.96)和 0.92(95%CI:0.86-0.99)。在 LSM 组中,与对照组相比,HCC 发生率的调整后 HR(95%CI)分别为 0.84(0.76-0.94)、0.87(0.81-0.94)和 1.08(1.00-1.16)。与肝脏相关的死亡率的调整后 HR(95%CI)分别为 0.92(0.80-1.06)、0.81(0.72-0.91)和 1.15(1.04-1.27)。

结论

LSM 降低了 CHB 患者 HCC 和死亡的风险。因此,应鼓励 CHB 患者积极进行 LSM,特别是戒酒和戒烟。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b21/10324530/e85e974edd5e/WJG-29-3843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b21/10324530/f90dea9ac756/WJG-29-3843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b21/10324530/e85e974edd5e/WJG-29-3843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b21/10324530/f90dea9ac756/WJG-29-3843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b21/10324530/e85e974edd5e/WJG-29-3843-g002.jpg

相似文献

1
Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B.生活方式改变对慢性乙型肝炎患者肝细胞癌发病率和死亡率的影响。
World J Gastroenterol. 2023 Jun 28;29(24):3843-3854. doi: 10.3748/wjg.v29.i24.3843.
2
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.一大群慢性乙型肝炎白种患者接受口服治疗5年后的肝细胞癌预测
J Hepatol. 2020 Jun;72(6):1088-1096. doi: 10.1016/j.jhep.2020.01.007. Epub 2020 Jan 22.
3
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data.他汀类药物的使用与慢性乙型肝炎患者肝细胞癌风险的关系:一项使用纵向全国人群队列数据模拟目标试验。
BMC Gastroenterol. 2023 Oct 25;23(1):366. doi: 10.1186/s12876-023-02996-w.
4
Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.增强纤维化评分和肝硬度测量的改善反映了肝细胞癌风险的降低。
Aliment Pharmacol Ther. 2019 Jun;49(12):1509-1517. doi: 10.1111/apt.15269. Epub 2019 Apr 25.
5
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.基于肝硬度的慢性乙型肝炎患者肝细胞癌风险评分优化。
J Hepatol. 2014 Feb;60(2):339-45. doi: 10.1016/j.jhep.2013.09.029. Epub 2013 Oct 12.
6
Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.接受抗病毒治疗的慢性乙型肝炎患者的肝硬化阶段及肝细胞癌发病率
Scand J Gastroenterol. 2017 Sep;52(9):1029-1036. doi: 10.1080/00365521.2017.1335773. Epub 2017 May 31.
7
The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.非侵入性方法在预测慢性乙型肝炎患者肝细胞癌和肝功能失代偿发展中的准确性。
J Clin Gastroenterol. 2012 Jul;46(6):518-25. doi: 10.1097/MCG.0b013e31825079f1.
8
Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.在实现病毒学应答后,慢性乙型肝炎患者患肝细胞癌的风险高于慢性丙型肝炎患者。
J Viral Hepat. 2017 Nov;24(11):990-997. doi: 10.1111/jvh.12723. Epub 2017 Jun 9.
9
The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B.韩国慢性乙型肝炎患者恩替卡韦治疗 5 年内及 5 年后发生肝细胞癌的风险。
Liver Int. 2018 Dec;38(12):2269-2276. doi: 10.1111/liv.13938. Epub 2018 Aug 19.
10
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.经FibroScan检测的亚肝硬化肝硬度与乙肝相关肝硬化患者肝细胞癌风险较低相关。
Hepatol Int. 2017 May;11(3):268-276. doi: 10.1007/s12072-017-9789-y. Epub 2017 Feb 21.

引用本文的文献

1
Epidemiology, natural history, and management of patients with CHB concurrent with MASLD.慢性乙型肝炎合并代谢相关脂肪性肝病患者的流行病学、自然史及管理
Clin Liver Dis (Hoboken). 2024 Jun 19;23(1):e0171. doi: 10.1097/CLD.0000000000000171. eCollection 2024 Jan-Jun.

本文引用的文献

1
Effects of Sorafenib and Quercetin Alone or in Combination in Treating Hepatocellular Carcinoma: In Vitro and In Vivo Approaches.索拉非尼和槲皮素单独或联合治疗肝细胞癌的作用:体外和体内方法。
Molecules. 2022 Nov 21;27(22):0. doi: 10.3390/molecules27228082.
2
Global burden of primary liver cancer in 2020 and predictions to 2040.2020 年全球原发性肝癌负担及 2040 年预测。
J Hepatol. 2022 Dec;77(6):1598-1606. doi: 10.1016/j.jhep.2022.08.021. Epub 2022 Oct 5.
3
Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes.
慢性乙型肝炎合并2型糖尿病患者的血糖负担与不良肝脏结局风险
Hepatology. 2023 Feb 1;77(2):606-618. doi: 10.1002/hep.32716. Epub 2022 Sep 21.
4
It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B.这并非仅仅关乎病毒——论可改变的生活方式因素在慢性乙型肝炎肝细胞癌发生发展中的重要性。
Hepatology. 2023 Feb 1;77(2):352-354. doi: 10.1002/hep.32798. Epub 2022 Oct 11.
5
Longitudinal Changes in Smoking Habits in Women and Subsequent Risk of Cancer.女性吸烟习惯的纵向变化与随后的癌症风险。
Am J Prev Med. 2022 Dec;63(6):894-903. doi: 10.1016/j.amepre.2022.07.001. Epub 2022 Aug 30.
6
Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.14 种 HCC 预测模型在 CHB 中的比较性能:在治疗过程中的连续时间点的动态验证。
Am J Gastroenterol. 2022 Sep 1;117(9):1444-1453. doi: 10.14309/ajg.0000000000001865. Epub 2022 Jun 10.
7
Molecular Mechanisms behind Safranal's Toxicity to HepG2 Cells from Dual Omics.基于双组学的藏红花醛对HepG2细胞毒性的分子机制
Antioxidants (Basel). 2022 Jun 7;11(6):1125. doi: 10.3390/antiox11061125.
8
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.慢性乙型肝炎患者体力活动与肝细胞癌风险的关联
Cancers (Basel). 2021 Jul 8;13(14):3424. doi: 10.3390/cancers13143424.
9
Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy.中心型肥胖与接受抗病毒治疗的慢性乙型肝炎患者肝细胞癌的相关性。
Aliment Pharmacol Ther. 2021 Aug;54(3):329-338. doi: 10.1111/apt.16469. Epub 2021 Jun 22.
10
Hawthorn Herbal Preparation from Attenuates In Vivo Carbon Tetrachloride -Induced Hepatic Fibrosis via Modulating Oxidative Stress and Inflammation.山楂草药制剂通过调节氧化应激和炎症减轻体内四氯化碳诱导的肝纤维化。
Antioxidants (Basel). 2020 Nov 24;9(12):1173. doi: 10.3390/antiox9121173.